651 related articles for article (PubMed ID: 25851110)
1. Resveratrol reduces amyloid-beta (Aβ₁₋₄₂)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans.
Regitz C; Fitzenberger E; Mahn FL; Dußling LM; Wenzel U
Eur J Nutr; 2016 Mar; 55(2):741-747. PubMed ID: 25851110
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
Regitz C; Dußling LM; Wenzel U
Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans Model of Alzheimer's disease.
Pu Z; Ma S; Wang L; Li M; Shang L; Luo Y; Chen W
Neuroscience; 2018 Nov; 392():25-37. PubMed ID: 30267833
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta (Aβ1-42)-induced paralysis in Caenorhabditis elegans is reduced by restricted cholesterol supply.
Regitz C; Wenzel U
Neurosci Lett; 2014 Jul; 576():93-6. PubMed ID: 24909620
[TBL] [Abstract][Full Text] [Related]
5. rBTI reduced β-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
Li J; Cui X; Ma X; Wang Z
Exp Gerontol; 2017 Mar; 89():78-86. PubMed ID: 28119052
[TBL] [Abstract][Full Text] [Related]
6. Monascin from Monascus-Fermented Products Reduces Oxidative Stress and Amyloid-β Toxicity via DAF-16/FOXO in Caenorhabditis elegans.
Shi YC; Pan TM; Liao VH
J Agric Food Chem; 2016 Sep; 64(38):7114-20. PubMed ID: 27554775
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta induced paralysis is reduced by cholecalciferol through inhibition of the steroid-signaling pathway in an Alzheimer model of
Leiteritz A; Schmiedl T; Baumanns S; Wenzel U
Nutr Neurosci; 2021 Feb; 24(2):82-89. PubMed ID: 30905309
[No Abstract] [Full Text] [Related]
8. Cranberry Extract Standardized for Proanthocyanidins Alleviates β-Amyloid Peptide Toxicity by Improving Proteostasis Through HSF-1 in Caenorhabditis elegans Model of Alzheimer's Disease.
Guo H; Cao M; Zou S; Ye B; Dong Y
J Gerontol A Biol Sci Med Sci; 2016 Dec; 71(12):1564-1573. PubMed ID: 26405062
[TBL] [Abstract][Full Text] [Related]
9. Carnosic acid ameliorated Aβ-mediated (amyloid-β peptide) toxicity, cholinergic dysfunction and mitochondrial defect in
Chen Y; Wang Y; Qin Q; Zhang Y; Xie L; Xiao J; Cao Y; Su Z; Chen Y
Food Funct; 2022 Apr; 13(8):4624-4640. PubMed ID: 35357374
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber
Tangrodchanapong T; Sornkaew N; Yurasakpong L; Niamnont N; Nantasenamat C; Sobhon P; Meemon K
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920352
[TBL] [Abstract][Full Text] [Related]
11. Copper ions influence the toxicity of β-amyloid(1-42) in a concentration-dependent manner in a Caenorhabditis elegans model of Alzheimer's disease.
Luo Y; Zhang J; Liu N; Luo Y; Zhao B
Sci China Life Sci; 2011 Jun; 54(6):527-34. PubMed ID: 21706413
[TBL] [Abstract][Full Text] [Related]
12. Vitexin prevents Aβ proteotoxicity in transgenic Caenorhabditis elegans model of Alzheimer's disease by modulating unfolded protein response.
Malar DS; Prasanth MI; Jeyakumar M; Balamurugan K; Devi KP
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22632. PubMed ID: 32926499
[TBL] [Abstract][Full Text] [Related]
13. Protective role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases.
Muñoz-Lobato F; Rodríguez-Palero MJ; Naranjo-Galindo FJ; Shephard F; Gaffney CJ; Szewczyk NJ; Hamamichi S; Caldwell KA; Caldwell GA; Link CD; Miranda-Vizuete A
Antioxid Redox Signal; 2014 Jan; 20(2):217-35. PubMed ID: 23641861
[TBL] [Abstract][Full Text] [Related]
14. Nicotine prevents in vivo Aβ toxicity in Caenorhabditis elegans via SKN-1.
Lu X; Zhang Y; Li H; Jin Y; Zhao L; Wang X
Neurosci Lett; 2021 Sep; 761():136114. PubMed ID: 34274434
[TBL] [Abstract][Full Text] [Related]
15. Deer antler extracts reduce amyloid-beta toxicity in a Caenorhabditis elegans model of Alzheimer's disease.
Du F; Zhao H; Yao M; Yang Y; Jiao J; Li C
J Ethnopharmacol; 2022 Mar; 285():114850. PubMed ID: 34801608
[TBL] [Abstract][Full Text] [Related]
16. Loss of proteostasis induced by amyloid beta peptide in brain endothelial cells.
Fonseca AC; Oliveira CR; Pereira CF; Cardoso SM
Biochim Biophys Acta; 2014 Jun; 1843(6):1150-61. PubMed ID: 24589617
[TBL] [Abstract][Full Text] [Related]
17. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
Wang C; Saar V; Leung KL; Chen L; Wong G
Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
[TBL] [Abstract][Full Text] [Related]
18. AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model.
Hassan WM; Merin DA; Fonte V; Link CD
Hum Mol Genet; 2009 Aug; 18(15):2739-47. PubMed ID: 19414486
[TBL] [Abstract][Full Text] [Related]
19. A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ
Xu J; Yuan Y; Zhang R; Song Y; Sui T; Wang J; Wang C; Chen Y; Guan S; Wang L
Bioorg Chem; 2019 Feb; 82():332-339. PubMed ID: 30428413
[TBL] [Abstract][Full Text] [Related]
20. Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes.
Ayyadevara S; Balasubramaniam M; Gao Y; Yu LR; Alla R; Shmookler Reis R
Aging Cell; 2015 Feb; 14(1):35-48. PubMed ID: 25510159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
